Summit Therapeutics (SMMT) EBT Margin Growth (1y) (2018 - 2022)

Summit Therapeutics (SMMT) EBT Margin Growth (1y) (2018 - 2022) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin Growth (1y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 1,526.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn 1,558.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -683.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn 452.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Summit Therapeutics 11.62 Bn 11.03 Bn - -

Historic Data

Download Data
DateValue
Sep 30, 2022 -651,730.00
Jun 30, 2022 3.72 Mn
Mar 31, 2022 12,633.00
Dec 31, 2021 -346,560.00
Sep 30, 2021 833,645.00
Jun 30, 2021 -3.37 Mn
Mar 31, 2021 -674,282.00
Dec 31, 2020 -742,202.00
Sep 30, 2020 -560,059.00
Mar 31, 2020 -72,045.00
Oct 31, 2019 -486,172.00
Jul 31, 2019 -500,876.00
Oct 31, 2018 -130,516.00
Jul 31, 2018 16,754.00
Apr 30, 2018 16,992.00